{
  "symbol": "CTMX",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": [
      "Biotechnology industry is prone to speculation",
      "Small-cap company with a market cap under $500 million",
      "Focus on oncology and innovative therapeutics"
    ],
    "riskScore": 7,
    "reason": "CytomX Therapeutics operates in the biotech sector, which is often subject to retail speculation, especially given its small-cap status and focus on innovative cancer treatments."
  }
}